Compare Nvidia Corp (NVDA) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Stryker Corporation — how do they compare? Nvidia Corp trades at $223.22 (market cap $5.40T), while Stryker Corporation trades at $277.44 (market cap $105.63B). The key difference: Nvidia Corp is far larger — about 51.1× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1.28%). Which is the better fit depends on your goals.
| NVDA | SYK | |
|---|---|---|
Market Cap | $5.40T | $105.63B |
Sector | Technology | Technology |
52-Week High | $235.75 | $388.79 |
52-Week Low | $165.17 | $275.39 |
Enterprise Value | $5.38T | $117.10B |
Dividend Yield | 0.45% | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $225.73, down 2.01% today, with a bullish technical signal from moving averages and support near $222. The company reported robust earnings beats in recent quarters, with Q3 2026 EPS expected at $2.47. Revenue surged to $130.50B in 2025, driving a net income margin of 63.66%, while valuation ratios like P/E of 28.54 reflect high growth expectations. Analysts maintain strong buy consensus amid AI-driven demand.
Outlook remains positive due to AI leadership and accelerating revenue, but risks include competition and market volatility. The stock offers significant upside to the $344.10 consensus target, though investors should monitor execution risks and macroeconomic headwinds.
Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.
The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
